An overview of polyamine metabolism in pancreatic ductal adenocarcinoma

Int J Cancer. 2018 May 15;142(10):1968-1976. doi: 10.1002/ijc.31155. Epub 2017 Dec 13.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest major cancers, with a five year survival rate of less than 8%. With current therapies only giving rise to modest life extension, new approaches are desperately needed. Even though targeting polyamine metabolism is a proven anticancer strategy, there are no reports, which thoroughly survey the literature describing the role of polyamine biosynthesis and transport in PDAC. This review seeks to fill this void by describing what is currently known about polyamine metabolism in PDAC and identifies new targets and opportunities to treat this disease. Due to the pleiotropic effects that polyamines play in cells, this review covers diverse areas ranging from polyamine metabolism (biosynthesis, catabolism and transport), as well as the potential role of polyamines in desmoplasia, autophagy and immune privilege. Understanding these diverse roles provides the opportunity to design new therapies to treat this deadly cancer via polyamine depletion.

Keywords: metabolism; pancreatic ductal adenocarcinoma; polyamine transport; polyamines.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Animals
  • Biogenic Polyamines / metabolism*
  • Carcinoma, Pancreatic Ductal / metabolism*
  • Humans
  • Pancreatic Neoplasms / metabolism*
  • Spermine / metabolism

Substances

  • Biogenic Polyamines
  • Spermine